Small-cell lung cancer: insights and new treatment options centering around DLL3
Small-cell lung cancer: insights and new treatme
Immunotherapy combinations in advanced-stage disease
Immunotherapy combinations in advanced-stage dis
EGFR-mutated NSCLC: practice-changing results and other notable findings
EGFR-mutated NSCLC: practice-changing results an
Innovative agents directed against RET, Trop-2, KRASG12C and HER2
Innovative agents directed against RET, Trop-2,
ALK-targeted adjuvant treatment and perioperative immunotherapy
ALK-targeted adjuvant treatment and perioperativ
Proposals for the 9th edition of the TNM classification
Proposals for the 9th edition of the TNM classif
MARS 2: no benefit of decortication in early-stage malignant mesothelioma
MARS 2: no benefit of decortication in early-stage mal
Trop-2–directed ADCs in conjunction with immunotherapy: EVOKE-02 and TROPION-Lung04
Trop-2–directed ADCs in conjunction with immunot
Refining first-line regimens for extensive-stage small-cell lung cancer
Refining first-line regimens for extensive-stage
Improved anti-EGFR strategies and other targeted innovations
Improved anti-EGFR strategies and other targeted
